Phase II - III Clinical Trials

Fully configured EDC study databases developed on SCiAN's EDCPRO platform are available for IND stage phase II - III clinical studies on a monthly subscription basis.

EDCPRO is a powerful and effective Web-based clinical data management system that incorporates SCiAN's 15 years of EDC knowledge and experience in managing IND-stage clinical trials.  Founded on our therapeutic area expertise, the intuitive user interface helps Study Coordinators, Monitors, Project & Data Managers, Medical Monitors and Statisticians complete their tasks with ease, efficiency and minimum administrative overhead.

Sponsors can select a fully configured EDC study database from our extensive library based on patient population, the clinical phase and the design of the study: 

Databases by Indication / Therapeutic Area

  • Oncology
  • Autoimmune - Inflammatory
  • Cardiovascular
  • CNS - Neurology - Pain
  • Dermatology
  • Diabetes - Metabolic
  • Gastroenterology
  • Infectious diseases
  • Respiratory.

Databases by Study Design1

  • Dose-escalation: open-label, single-arm
  • Dose-escalation: randomized, placebo-controlled (blinded) design
  • Parallel group randomized (blinded) dose ranging w/out placebo group
  • 2x2 Latin-square and other cross-over designs
  • Dose-escalation  desigs
  • 2-stage phase II designs 
  • Open label and other parallel group designs
  • Adaptive designs
  • Multi-stage designs
  • Sequential designs.

1) PK, PD and biomarker sub-studies supported